COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 253 clinical trials
featured
Study to Evaluate the Safety Tolerability and Efficacy of BGE-175 in Participants 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

The primary objectives of this study are to evaluate the safety, tolerability, and efficacy of BGE-175 in participants 60 years of age hospitalized with documented COVID-19.

  • 0 views
  • 29 Mar, 2021
featured
  • 208 views
  • 13 Aug, 2020
  • 1 location
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL (diffuse large B-cell lymphoma (DLBCL) NOS [de novo or transformed follicular lymphoma (tFL)], double/triple-hit lymphoma [DHL/THL], follicular lymphoma Grade 3B [FL3B], primary central …

  • 1875 views
  • 26 Mar, 2021
  • 15 locations
Covid-19 Vaccination in Adolescents

parents, and between the children and their parents. Hypothesis to be tested The safety profile and the magnitude and durability of immune responses to the 3 COVID-19 vaccines in young adolescents

  • 0 views
  • 21 Apr, 2021
  • 1 location
LYT-100 in Post-acute COVID-19 Respiratory Disease

This study is a randomized, double-blind, parallel arm study to evaluate the safety and efficacy of LYT-100 compared to placebo in adults with post-acute COVID-19 respiratory complications

  • 0 views
  • 10 May, 2021
  • 17 locations
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers

The disease promoted by coronavirus (COVID-19) is caused by Severe Acute Respiratory Syndrome (SARS) caused by Coronavirus type 2 (CoV2), being the first cases identified in December 2019 in

  • 0 views
  • 27 Jan, 2021
  • 1 location
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

/moderate to serve particularly in high risk patients. Recognizing this limitation and urgency of finding a treatment for COVID-19, the U.S. Food and Drug Administration (FDA) has issued an Emergency Use

  • 0 views
  • 22 Apr, 2021
  • 3 locations
Emergency Department-Initiated Buprenorphine Validation Network Trial

This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation facilitation strategies to provide ED-initiated buprenorphine (BUP) for patients presenting with opioid use disorder (OUD) who are not receiving medications for opioid use disorder (MOUD). Once implementation is adequately …

  • 226 views
  • 16 Apr, 2021
  • 37 locations
COVIDIG (COVID-19 Hyper-ImmunoGlobulin)

The objective of this study is to evaluate the efficacy and safety of 5131A for hospitalized patients of COVID-19.

  • 0 views
  • 26 Jan, 2021
COVidIVERmectin: Ivermectin for Treatment of Covid-19

Prospective, multi-centre, randomized, double-blind trial to assess efficacy and safety of ivermectin for the treatment of initial infection with SARS-CoV2 infection. Study arms: A) placebo B) ivermectin 600 g/kg daily for 5 consecutive days (I_600) + placebo. C) ivermectin 1200 g/kg daily at empty stomach with water for 5 consecutive …

SARS
ivermectin
  • 5 views
  • 23 May, 2021
  • 7 locations